MY146568A - Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
- Google Patents
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Canada IncfiledCriticalShire Canada Inc
Priority to MYPI20071428ApriorityCriticalpatent/MY146568A/en
Publication of MY146568ApublicationCriticalpatent/MY146568A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
THERE IS PROVIDED A METHOD FOR RESOLVING A COMPOUND OF FORMULA III, IN THE CIS CONFIGURATION: THERE IS ALSO PROVIDED A PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUND OF FORMULA I OR II: WHEREIN: R1, R2, R3 ARE AS DEFINED HEREIN, THE METHOD AND PROCESS INVOLVING THE PRODUCTION, RECOVERY AND CONVERSION OF DIASTEREOMERIC SALTS.
MYPI20071428A2007-08-242007-08-24Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
MY146568A
(en)
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1??-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof.
METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE
Process for the preparation of 1,3-dihydro-2h-3-benzazepin-2-one and application to the preparation of ivabradine and their pharmaceutically acceptable salts
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof